Airain Ltd’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Airain Ltd's PFE Position: Q2 2017 in Review
Airain Ltd reduced its Pfizer (PFE) stake by 39% in Q2 2017, selling an estimated $5.75M and leaving 285,333 shares worth $9.09M. The position accounts for 0.4% of the portfolio, ranked #71.
Airain Ltd first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. The position peaked at $15.2M in Q1 2017. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- Airain Ltd held 285,333 shares of Pfizer worth $9.09M as of Q2 2017.
- Airain Ltd sold 182,433 Pfizer shares in Q2 2017, an estimated $5.75M.
- Pfizer made up 0.4% of Airain Ltd's portfolio in Q2 2017, its #71 holding.
- Airain Ltd first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
- Airain Ltd's Pfizer position peaked at $15.2M in Q1 2017.
- 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.